Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration

Drugs of the Future

Volumn 36, Issue 9, 2011, Pages 713-718

  Ardeljan, D ^a   Tuo, J ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; AUTOANTIBODY; CARBOXYETHYLPYRROLE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBODY TITER; BLINDNESS; DIET SUPPLEMENTATION; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; NONHUMAN; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW;

EID: 84952985992     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2011.036.09.1678338     Document Type: Review

References (56)

1. Pascolini, D., Mariotti, S.P., Pokharel, G.P., Pararajasegaram, R., Etya'ale, D., Negrel, A.D., Resnikoff, S. 2002 global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004, 11(2): 67-115. (Pubitemid 38530465)
2. Congdon, N., O'Colmain, B., Klaver, C.C. et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004, 122(4): 477-85. (Pubitemid 38456282)
3. Visual impairment and blindness. World Health Organization, April 2011. http://www.who.int/mediacentre/factsheets/fs282/en/index.html. Accessed June 6, 2011.
4. Friedman, D.S., O'Colmain, B.J., Munoz, B. et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004, 122(4): 564-72. (Pubitemid 38456293)
5. Jager, R.D., Mieler, W.F., Miller, J.W. Age-related macular degeneration. N Engl J Med 2008, 358(24): 2606-17.
6. de Jong, P.T. Age-related macular degeneration. N Engl J Med 2006, 355(14): 1474-85.
7. Ni, J., Yuan, X., Gu, J., Yue, X., Gu, X., Nagaraj, R. H., Crabb, J.W. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Mol Cell Proteomics 2009, 8(8): 1921-33.
8. Chen, Y., Bedell, M., Zhang, K. Age-related macular degeneration: Genetic and environmental factors of disease. Mol Interv 2010, 10(5): 271-81.
9. Yu, Y., Bhangale, T.R., Fagerness, J. et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011, Epub ahead of print.
10. Seddon, J.M., Willett, W.C., Speizer, F.E., Hankinson, S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996, 276(14): 1141-6. (Pubitemid 26329740)
11. Age-Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119(10): 1417-36.
12. Crabb, J.W., Miyagi, M., Gu, X. et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002, 99(23): 14682-7. (Pubitemid 35334544)
13. Gu, J., Pauer, G.J., Yue, X. et al.; and the Clinical Genomic and Proteomic AMD Study Group. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics 2009, 8(6): 1338-49.
14. Gu, X., Meer, S.G., Miyagi, M., Rayborn, M.E., Hollyfield, J.G., Crabb, J.W., Salomon, R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003, 278(43): 42027-35. (Pubitemid 37310467)
15. Gu, X., Sun, M., Gugiu, B., Hazen, S., Crabb, J.W., Salomon, R.G. Oxidatively truncated docosahexaenoate phospholipids: Total synthesis, generation, and peptide adduction chemistry. J Org Chem 2003, 68(10): 3749-61. (Pubitemid 36576624)
16. Fliesler, S.J., Anderson, R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983, 22(2): 79-131.
17. Edwards, A.O., Ritter, R., Abel, K.J., Manning, A., Panhuysen, C., Farrer, L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308(5720): 421-4. (Pubitemid 40530082)
18. Katta, S., Kaur, I., Chakrabarti, S. The molecular genetic basis of age-related macular degeneration: An overview. J Genet 2009, 88(4): 425-49.
19. Dewan, A., Liu, M.G., Hartman, S. et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314(5801): 989-92. (Pubitemid 44749943)
20. Sobrin, L., Reynolds, R., Yu, Y. et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol 2011, 151(2): 345-52.
21. Ryu, E., Fridley, B.L., Tosakulwong, N., Bailey, K.R., Edwards, A.O. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. Mol Vis 2010, 16: 2811-21.
22. Kabasawa, S., Mori, K., Horie-Inoue, K. et al. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 2011, 118(6): 1082-8.
23. Cackett, P., Yeo, I., Cheung, C.M.G. et al. Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and agerelated macular degeneration in Chinese persons. Ophthalmology 2011, 118(5): 846-52.
24. Fraser-Bell, S., Wu, J., Klein, R., Azen, S.P., Hooper, C., Foong, A.W.P., Varma, R. Cardiovascular risk factors and age-related macular degeneration: The Los Angeles Latino Eye Study. Am J Ophthalmol 2008, 145(2): 308-16.
25. Haas, P., Aggermann, T., Steindl, K. et al. Genetic cardiovascular risk factors and age-related macular degeneration. Acta Ophthalmol 2011, 89(4): 335-8.
26. Klein, R., Klein, B.E.K., Tomany, S.C., Cruickshanks, K.J. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2003, 110(6): 1273-80.
27. van Leeuwen, R., Ikram, M.K., Vingerling, J.R., Witteman, J.C.M., Hofman, A., de Jong, P. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: The Rotterdam Study. Invest Ophthalmol Vis Sci 2003, 44(9): 3771-7. (Pubitemid 37047945)
28. Hogg, R.E., Woodside, J.V., Gilchrist, S. et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008, 115(6): 1046-52.
29. Iriyama, A., Fujiki, R., Inoue, Y. et al. A2E, a pigment of the lipofuscin of retinal pigment epithelial cells, is an endogenous ligand for retinoic acid receptor. J Biol Chem 2008, 283(18): 11947-53.
30. Ng, K.P., Gugiu, B., Renganathan, K. et al. Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics 2008, 7(7): 1397-405. (Pubitemid 352038281)
31. Murdaugh, L.S., Wang, Z., Del Priore, L.V., Dillon, J., Gaillard, E.R. Agerelated accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane. Exp Eye Res 2010, 90(5): 564-71.
32. Iriyama, A., Inoue, Y., Takahashi, H., Tamaki, Y., Jang, W.D., Yanagi, Y. A2E, a component of lipofuscin, is pro-angiogenic in vivo. J Cell Physiol 2009, 220(2): 469-75.
33. Ramkumar, H.L., Zhang, J., Chan, C.C. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010, 29(3): 169-90.
34. Ebrahem, Q., Renganathan, K., Sears, J. et al. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc Natl Acad Sci U S A 2006, 103(36): 13480-4. (Pubitemid 44380133)
35. West, X.Z., Malinin, N.L., Merkulova, A.A. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467(7318): 972-6.
36. Hollyfield, J.G., Bonilha, V.L., Rayborn, M.E. et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008, 14(2): 194-8. (Pubitemid 351214555)
37. Hollyfield, J.G., Perez, V.L., Salomon, R.G. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 2010, 41(2-3): 290-8.
38. Patel, M., Chan, C.C. Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 2008, 30(2): 97-110.
39. Ding, X., Patel, M., Chan, C.C. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009, 28(1): 1-18.
40. Rutkowski, M.J., Sughrue, M.E., Kane, A.J., Ahn, B.J., Fang, S., Parsa, A.T. The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 2010, 59(11): 897-905.
41. Langer, H.F., Chung, K.J., Orlova, V.V. et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010, 116(22): 4395-403.
42. Kahr, W.H. Complement halts angiogenesis gone wild. Blood 2010, 116(22): 4393-4.
43. Nozaki, M., Raisler, B.J., Sakurai, E. et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 2006, 103(7): 2328-33. (Pubitemid 43271669)
44. Zhou, J., Kim, S.R., Westlund, B.S., Sparrow, J.R. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci 2009, 50(3): 1392-9.
45. Sparrow, J.R. Bisretinoids of RPE lipofuscin: Trigger for complement activation in age-related macular degeneration. Adv Exp Med Biol 2010, 703: 63-74.
46. Ho, L., van Leeuwen, R., Witteman, J.C. et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and {omega}-3 fatty acids: The Rotterdam Study. Arch Ophthalmol 2011, 129(6): 758-66.
47. Tuo, J., Ross, R.J., Herzlich, A.A. et al. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol 2009, 175(2): 799-807.
48. German, O.L., Insua, M.F., Gentili, C., Rotstein, N.P., Politi, L.E. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochem 2006, 98(5); 1507-20. (Pubitemid 44200442)
49. Rotstein, N.P., Politi, L.E., German, O.L., Girotti, R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003, 44(5): 2252-9. (Pubitemid 36520324)
50. Bazan, N.G. Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005, 15(2): 159-66. (Pubitemid 40546172)
51. Mukherjee, P.K., Marcheselli, V.L., de Rivero Vacari, J.C., Gordon, W.C., Jackson, F.E., Bazan, N.G. Photoreceptor outer segment phagocytosis attenuates oxidative-stress induced apoptosis with concomitant neuroprotecting D1 synthesis. Proc Natl Acad Sci U S A 2007, 104(32): 13158-63. (Pubitemid 351737609)
52. Kaarniranta, K., Salminen, A. NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). Exp Gerontol 2009, 44(11): 685-8.
53. Schweigert, F.J., Reimann, J. [Micronutrients and their relevance for the eye - Function of lutein, zeaxanthin and omega-3 fatty acids.]. Klin Monbl Augenheilkd 2011, 228(6): 537-43.
54. Pawlosky, R.J., Denkins, Y., Ward, G., Salem, N. Jr. Retinal and brain accretion of long-chain polyunsaturated fatty acids in developing felines: The effects of corn oil-based maternal diets. Am J Clin Nutr 1997, 65(2): 465-72. (Pubitemid 27130755)
55. Neuringer, M., Connor, W.E., Van Petten, C., Barstad, L. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest 1984, 73(1): 272-6. (Pubitemid 14222673)
56. Kishan, A.U., Modjtahedi, B.S., Martins, E.N., Modjtahedi, S.P., Morse, L.S. Lipids and age-related macular degeneration. Surv Ophthalmol 2011, 56(3): 195-213.